Fallopian tube removal may lower ovarian cancer risk
UPDATES AND NEWS
The Lustgarten Foundation and Break Through Cancer Announce New Clinical Trial Evaluating KRAS-targeted Immunotherapy Strategy for Pancreatic Cancer
Most ‘Ovarian Cancer’ Isn’t. And That Fact Can Save Lives | New York Times
Breaking Through Pancreatic Cancer with Revolution Medicines
Break Through Cancer and the Lustgarten Foundation Launch New Pancreatic Cancer Initiative | The ASCO Post
BE PART OF THE MISSION
Stay Informed, Make an Impact
Subscribe
Be the first to hear about cutting-edge research, pioneering projects, and the latest advancements in Break Through Cancer science. Sign up to stay informed.
Give
Your contribution fuels groundbreaking research in some of the most challenging cancers. Every gift accelerates progress. For more information please contact Michaela Forand at MF@breakthroughcancer.org or 1-800-757-9881 ext 2.
